GlassScriptPhysician profile
Richard J Leung
NPI 1689845083
$4,194.45
in general payments reported to CMS, 2019-2025
19 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,614 · 2020: $417 · 2021: $288 · 2022: $196 · 2023: $420 · 2024: $135 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $626.95 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $473.31 | 2019-2021 | |
| Alcon Vision LLC | $455.35 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $404.54 | 2019-2020 | |
| Allergan, INC. | $325.42 | 2019-2020 | |
| Biogen, INC. | $278.68 | 2022-2023 | Tysabri, Vumerity |
| Abbvie INC. | $225.00 | 2022-2025 | |
| Eyevance Pharmaceuticals LLC | $199.98 | 2019 | |
| Carl Zeiss Meditec, INC. | $178.13 | 2019 | |
| Kala Pharmaceuticals, INC. | $157.88 | 2019 | |
| Glaukos Corporation | $154.44 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $135.00 | 2024 | Airsupra |
| Portola Pharmaceuticals, LLC | $124.99 | 2019 | |
| Bausch & Lomb Americas INC. | $123.90 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $113.40 | 2023 | Zeposia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $102.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $47.22 | 2019 | |
| Shire North American Group INC | $47.12 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.